BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 542901)

  • 21. [Progesterone and abortion].
    Hashiguchi S
    Sanfujinka No Jissai; 1969 Dec; 18(13):1140-6. PubMed ID: 5395804
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of oxyprogesterone-capronate in threatened abortion].
    Pashchenko AG
    Vopr Okhr Materin Det; 1968 Apr; 13(4):59-63. PubMed ID: 5703209
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of sex hormones in pregnancy in Spain 1976-1984].
    García Alonso F; Rodríguez Pinilla E; Martínez Frías ML; Marcos Herrero F; Salvador J; Levy Mafhoda M; Dal Re Saavedra M
    Med Clin (Barc); 1988 Feb; 90(5):183-5. PubMed ID: 3352360
    [No Abstract]   [Full Text] [Related]  

  • 25. Galactorrhea and abnormal menses associated with a long-acting progesterone.
    Bolognese RJ; Piver MS; Feldman JD
    JAMA; 1967 Jan; 199(1):42-3. PubMed ID: 6071126
    [No Abstract]   [Full Text] [Related]  

  • 26. [Attempted gestanone therapy of imminent and habitual abortions].
    Zymek-Giermańska T; Sward J
    Wiad Lek; 1965 Sep; 18(18):1447-50. PubMed ID: 5840901
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiology should be supported with evidence in progesterone administration for threatened miscarriage -- authors' reply.
    Kalinka J; Szekeres-Bartho J; Kalinka J
    Am J Reprod Immunol; 2005 Dec; 54(6):397. PubMed ID: 16305666
    [No Abstract]   [Full Text] [Related]  

  • 28. [Colpocytological examination in the evaluation of results of hormonal therapy in threatened miscarriage].
    Fedorova MV; Khachaturian EA; Shchepotina NA
    Sov Med; 1973 Oct; 36(10):135-8. PubMed ID: 4789197
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of allylestrenol progesterone action on the cervical mucus and the vaginal cytology in threatened abortion, Preliminary report].
    Matute Rafray MM; Ruiz Velasco V; Conde BI; Lozano C
    Ginecol Obstet Mex; 1971 Dec; 30(182):671-9. PubMed ID: 5138659
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proceedings: Threatened abortion-- therapy and abnormality incidence].
    Wallner HJ; Waidl E; Welsch H
    Arch Gynakol; 1973 Sep; 214(1):83-4. PubMed ID: 4801541
    [No Abstract]   [Full Text] [Related]  

  • 31. [Threatened abortion. Development and treatment].
    Maretti M; Vitiello N; Lacreta O
    Matern Infanc (Sao Paulo); 1970; 29(1):71-8. PubMed ID: 5516901
    [No Abstract]   [Full Text] [Related]  

  • 32. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 33. Comments on "Cardiovascular birth defects and prenatal exposure to female sex hormones".
    Wiseman RA
    Teratology; 1994 Mar; 49(3):172-3; discussion 174-7. PubMed ID: 8059423
    [No Abstract]   [Full Text] [Related]  

  • 34. [Abortive properties of tetracyclines in mice. Hormone treatments].
    Boucher D
    Arch Sci Physiol (Paris); 1969; 23(4):481-516. PubMed ID: 5345878
    [No Abstract]   [Full Text] [Related]  

  • 35. [The pharmacodynamic action of caffeine. Deductions in clinical obstetrics].
    Crainicianu A
    Minerva Ginecol; 1971 Dec; 23(23):984-9. PubMed ID: 5167813
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possibilities of change of sex chromatin. Influence of age and of progesterone].
    Bertorello G; Imparato E
    Arch Ostet Ginecol; 1967; 72(6):772-9. PubMed ID: 5629180
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormonal treatment of spontaneous abortions--our experience].
    Katsulov A; Donchev V
    Akush Ginekol (Sofiia); 1985; 24(6):1-4. PubMed ID: 4091205
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our experience in treating spontaneous abortions using the preparation Supradyn-N].
    Milchev N; Krŭsteva M; Piperkov T; Malinova M; Pekhlivanov B
    Akush Ginekol (Sofiia); 1987; 26(4):18-23. PubMed ID: 3674317
    [No Abstract]   [Full Text] [Related]  

  • 39. [The action of progesterone on uterine motoricity. Therapeutic deductions].
    Crainicianu A
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):295-301. PubMed ID: 5630242
    [No Abstract]   [Full Text] [Related]  

  • 40. [The pathogenesis of diabetes insipidus in pregnancy (description of a case)].
    Laghi A; Tomasillo MR
    Arch Ostet Ginecol; 1980; 85(4):297-305. PubMed ID: 7344669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.